SPECTRAPROBE-PLR MODEL 900 OPTILASE CONTACT LASER

Device, Angioplasty, Laser, Coronary

FDA Premarket Approval P870043

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceSPECTRAPROBE-PLR MODEL 900 OPTILASE CONTACT LASER
Classification NameDevice, Angioplasty, Laser, Coronary
Generic NameDevice, Angioplasty, Laser, Coronary
ApplicantTRIMEDYNE, INC.
Date Received1987-07-29
Decision Date1988-06-30
Notice Date1988-08-10
PMAP870043
SupplementS
Product CodeLPC
Docket Number88M-0264
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address TRIMEDYNE, INC. 25901 Commercentre Dr lake Forest, CA 92630

Supplemental Filings

Supplement NumberDateSupplement Type
P870043Original Filing
S016 1991-11-19 Normal 180 Day Track
S015 1991-08-29 Normal 180 Day Track
S014 1991-04-23 Normal 180 Day Track
S013 1990-12-06 Normal 180 Day Track
S012
S011 1990-04-30 Normal 180 Day Track
S010 1989-12-22 Normal 180 Day Track
S009 1989-10-26 Normal 180 Day Track
S008 1989-09-28 Normal 180 Day Track
S007 1989-02-03 Normal 180 Day Track
S006 1989-01-10 Normal 180 Day Track
S005 1988-12-27 Normal 180 Day Track
S004 1988-11-23 Normal 180 Day Track
S003 1988-11-03 Normal 180 Day Track
S002 1988-10-13 Normal 180 Day Track
S001 1988-09-14 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.